Step 2 - Clinician Review
Patients with cardiovascular risk factors may therefore find a GLP-1RA more appropriate owing to the improvements in cardiometabolic parameters that have been observed with this drug class [10, 37, 46, 47]
To prevent unauthorised sale, unsupervised use, and other malpractices, the Drug Controller of India has intensified its regulatory surveillance, warning that the drugs can lead to serious side effects if not taken under strict medical supervision
Tesamorelin also offers muscle preservation benefits through GH and IGF-1 pathways, making it valuable for researchers prioritizing safe muscle maintenance during body recomposition
Download the guide now to get expert strategies and support your patients journey with GLP-1 treatments: #Resources #ClinicianGuide #GLP-1 Managing GLP-1 therapy side effects with a Clinician Guide Struggling with GLP-1 therapy side effects